23rd January 2008 - Antitope Ltd., a privately-held antibody and protein engineering company, today announced a research agreement with the China Synthetic Rubber Corporation (CSRC). Under the Agreement, Antitope will apply Composite Human AntibodyTM technology to produce two fully humanized antibodies for use in oncology.
